Baselaunch visual pills

We help building transformative healthcare ventures

BaseLaunch visual stethoscope

Applications open on January 30, 2018

BaseLaunch visual pills

We help building
transformative
healthcare ventures

BaseLaunch visual stethoscope

Applications
open on January 30, 2018

Four strong pillars to accelerate groundbreaking healthcare innovations

The BaseLaunch accelerator is specifically tailored to the needs of healthcare startups. It offers carefully selected ventures non-dilutive financial support, no strings attached access to its Healthcare Partners, knowledge from highly experienced advisors, as well as a state-of-the-art infrastructure. Furthermore, BaseLaunch embeds startups deeply within the Basel region, one of Europe’s finest biotech ecosystem.
Grants for startups
Non-dilutive funding
Industry access for healthcare startups
Industry access
Insights biotech and pharma ecosystem
Expert knowledge
Infrastructure and laboratories healthcare startups
Infrastructure

Healthcare Partners

Johnson & Johnson Innovation Logo
Novartis Venture Fund Logo
Pfizer Logo
Roivant
“We are pleased to help energize the Basel region’s center of gravity for European healthcare ventures, offering startups the support they need to accelerate their ideas.”

Dr. Anja König, Managing Director, Novartis Venture Fund

“Through Pfizer’s support of BaseLaunch, we hope to advance the pace at which promising science is translated into potential medicines.”

Uwe Schoenbeck, Chief Scientific Officer, External Research and Development Innovation & Senior Vice President, Worldwide Research and Development, Pfizer

“This program offers grants and lab space to selected startups – with no strings attached – illustrating that what we want to create here is an optimal environment for startups that focuses on supporting transformative science and great ideas in Switzerland.”

Richard Mason, Head of the Johnson & Johnson London Innovation Centre

“We are pleased to help energize the Basel region’s center of gravity for European healthcare ventures, offering startups the support they need to accelerate their ideas.”

Dr. Anja König, Managing Director, Novartis Venture Fund

“Through Pfizer’s support of BaseLaunch, we hope to advance the pace at which promising science is translated into potential medicines.”

Uwe Schoenbeck, Chief Scientific Officer, External Research and Development Innovation & Senior Vice President, Worldwide Research and Development, Pfizer

“This program offers grants and lab space to selected startups – with no strings attached – illustrating that what we want to create here is an optimal environment for startups that focuses on supporting transformative science and great ideas in Switzerland.”

Richard Mason, Head of the Johnson & Johnson London Innovation Centre

News & Events